The Independent Scientific Committee on Drugs applied MCDA to model and assess 20 drugs on 16 criteria. Their findings (in 2010) correlated poorly with the current UK drug classification, which was, and is, not based simply on considerations of harm. We re-present their analyses in Annalisa to permit exploration of the effect of changing the criterion Weightings and harm Ratings.